Charlie Hunnam stood before an audience in Los Angeles on Friday, 22 May 2026, at a SAG‑AFTRA Foundation Conversations event for Monster: The Ed Gein Story and described why he took on one of cinema’s darkest true‑crime figures.
Hunnam, who rose to wider attention as Lin Ford in the 2022 Apple TV+ series Shantaram, told the crowd that the role pushed him: "I think I read every book written on Ed Gein, and it started to become impossibly bleak to me. I really wanted to challenge myself in my career at this point in life, and this seemed like a golden opportunity to play a type of character I've never played before." He added, "But the darkness of it really scared me. And finding the truth in who he was felt like it was going to force me to go to a place that I didn’t necessarily want to go."
The moment matters because it follows a high‑profile turn on television that did not continue: Shantaram premiered in 2022, ran 12 episodes and cost an estimated $100 million to mount, but Apple TV+ announced in December 2022 that the series would not return for a second season. Hunnam had starred as Lin Ford, a former paramedic, heroin addict and bank robber who escapes an Australian prison and tries to remake himself in 1980s Bombay — the series adaptation of Gregory David Robert's novel.
Production on Shantaram itself reads like a chronicle of obstacles that shadowed the show from the start. Filming began in October 2019 and was suspended in February 2020 after two episodes; the pause was initially because of the Indian monsoon season and then because of a writing backlog following the departure of showrunner Eric Warren Singer. Crews resumed briefly in India in late 2020, moved the shoot to Thailand because of COVID‑19 restrictions, and finally wrapped in late 2021 before the series was released in 2022.
The reception was mixed in ways that sharpen the present story. Critics were divided — Collider said Hunnam had "never been better," while RogerEbert.com praised a "vibrant international cast of characters" even as it called the show "more than a little bloated." Other outlets labeled it a "slow‑moving thriller" (Decider) or argued "the series should have been a movie" (Slant Magazine). On Rotten Tomatoes the Tomatometer sits at 57 percent while an 86 percent audience Popcornmeter score shows viewers were far more forgiving.
That split — and the scale of the investment — creates friction. A $100 million budget and an expansive shoot carried expectations of a long‑running franchise; instead, the series ended after a single season. By contrast, some contemporary prestige shows score much higher on the Tomatometer — 95 percent for Severance, 90 percent for Ted Lasso and 97 percent for Slow Horses — underscoring how critical acclaim and platform patience sometimes move in different directions than audience enthusiasm or budgetary ambition.
Hunnam’s remarks on Friday framed his next move as deliberate rather than accidental. He spoke of seeking a challenge and of being pulled toward a role that would force him into darker terrain. For an actor whose Shantaram turn came amid extended, costly production and a one‑season run, the choice to play Ed Gein is, by his own account, a conscious pivot toward riskier, character‑first work.
That pivot answers the obvious question: is Hunnam regrouping after Shantaram’s short life on television? The evidence points to yes. Faced with a high‑profile series that cost a fortune to make and finished with a polarized reception, Hunnam has chosen projects that test him as a performer — and he has said so in his own words. Whether audiences follow him into the darkness of Monster: The Ed Gein Story will be the next measure of how successful that recalibration proves to be.
